scholarly journals HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 1 REVERSE TRANSCRIPTASE RESISTANCE MUTATIONS IN HEPATITIS B VIRUS (HBV)-HIV-COINFECTED PATIENTS TREATED FOR HBV CHRONIC INFECTION ONCE DAILY WITH 10 MILLIGRAMS OF ADEFOVIR DIPIVOXIL COMBINED WITH LAMIVUDINE

2002 ◽  
Vol 11 (4) ◽  
pp. 246-247
Author(s):  
&NA;
2002 ◽  
Vol 46 (5) ◽  
pp. 1586-1588 ◽  
Author(s):  
Constance Delaugerre ◽  
Anne-Geneviève Marcelin ◽  
Vincent Thibault ◽  
Gilles Peytavin ◽  
Tony Bombled ◽  
...  

ABSTRACT Adefovir dipivoxil (ADV) at a suboptimal concentration for human immunodeficiency virus type 1 (HIV-1) (10 mg once daily) can be used to treat hepatitis B virus (HBV) infection in HIV-1-HBV-coinfected patients and does not, even in the case of uncontrolled HIV-1 replication, select for either ADV mutations at codons 65 and 70 or any other particular HIV-1 reverse transcriptase resistance profile.


2018 ◽  
Vol 3 (11) ◽  
pp. 3313-3317 ◽  
Author(s):  
Satoru Kohgo ◽  
Shuhei Imoto ◽  
Ryoh Tokuda ◽  
Yuki Takamatsu ◽  
Nobuyo Higashi-Kuwata ◽  
...  

1988 ◽  
Vol 158 (3) ◽  
pp. 666-667 ◽  
Author(s):  
Y. Lazizi ◽  
L. G. Keros ◽  
J.-F. Delfraissy ◽  
F. Boue ◽  
P. Dubreuil ◽  
...  

Medical Care ◽  
1996 ◽  
Vol 34 (1) ◽  
pp. 1-10 ◽  
Author(s):  
JYOTI RAU ◽  
JULIE L. CROSS ◽  
LOUISE K. HOFHERR ◽  
K. MICHAEL PEDDECORD ◽  
ABRAM S. BENENSON ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document